Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization Criteria and Efficiency of a Thermoelectric Generator.

Entropy (Basel, Switzerland)·2022
Same author

Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model.

Theoretical biology & medical modelling·2015
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 22, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

11.2K

Dendritic Immunotherapy Improvement for an Optimal Control Murine Model.

J C Rangel-Reyes1, J C Chimal-Eguía1, E Castillo-Montiel1

  • 1Laboratorio de Simulación y Modelado, Centro de Investigación en Computación, Instituto Politécnico Nacional, Av. Juan de Dios Bátiz, Esq. Miguel Othón de Mendizábal, Col. Nueva Industrial Vallejo Delegación Gustavo A. Madero, 07738 Ciudad de México, Mexico.

Computational and Mathematical Methods in Medicine
|September 16, 2017
PubMed
Summary

Mathematical modeling optimizes dendritic cell (DC) vaccine protocols for cancer treatment. Improving DC delivery to lymph nodes is crucial for effective immunotherapy against tumors.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
09:09

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

Published on: April 18, 2016

16.0K

Related Experiment Videos

Last Updated: Feb 22, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

11.2K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
09:09

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

Published on: April 18, 2016

16.0K

Area of Science:

  • Immunology
  • Computational Biology
  • Oncology

Background:

  • Current immunotherapy protocols rely on therapist experience.
  • Dendritic cell (DC) vaccine efficacy is limited by immunosuppression and poor lymph node transfer.
  • Mathematical modeling offers a data-driven approach to optimize treatment strategies.

Purpose of the Study:

  • To develop a mathematical model for evaluating DC vaccine therapy in cancer.
  • To optimize therapeutic protocols using optimal control algorithms.
  • To investigate the impact of DC delivery and injection timing on treatment outcomes.

Main Methods:

  • A mathematical murine model was created to simulate DC injections.
  • Optimal control algorithms were used to refine therapeutic protocols for minimizing tumor mass.
  • Bolus injections were modeled as opposed to continuous dosing.
  • Experimental validation was performed on melanoma-bearing mice.

Main Results:

  • The model accurately reflects experimental outcomes in mice with melanoma.
  • The percentage of dendritic cells reaching lymph nodes significantly impacts therapy success.
  • Optimized dosing timing, determined by the model, can improve therapeutic protocols.

Conclusions:

  • Mathematical modeling and optimal control can supplement clinical intuition for immunotherapy protocols.
  • Enhancing dendritic cell delivery to lymph nodes is critical for improving cancer vaccine effectiveness.
  • Further research into improved DC vaccine delivery methods is warranted.